Global CM Capabilities Cangene bioPharma operates Emergent's contract manufacturing site, offering aseptic fill/finish for liquids and lyophilized products in vials and syringes. The facility supports 24 commercial products and has contributed to more than 185 clinical products since 1990, with approvals in major regions and distribution to over fifty countries.

Strategic Backing Being part of Emergent BioSolutions, the site offers strategic backing and potential cross sell opportunities into government, healthcare, and defense channels, enabling scale up and access to a broader customer base.

Regulatory Maturity The manufacturing site has regulatory approvals and inspections across US, EU, Brazil, Middle East, and Japan, indicating a mature quality system that reduces onboarding risk for new clients seeking compliant, globally exportable fill/finish manufacturing.

Global Reach With established global distribution and a track record of handling diverse products, the facility can support international supply chains for biotech and pharma partners looking to reach multiple markets from a single manufacturing partner.

Growth Ready Partner The combination of aseptic fill finish capabilities, commercial and clinical product experience, and a mid size scale profile makes this site a flexible growth ready partner for growth stage biotechs and small to mid market firms seeking reliable manufacturing and faster time to market.